Rubenstein Law Partner, Miriam Fresco Agrait, Appointed to Plaintiffs' Leadership in the Depo-Provera Litigation

MIAMI, March 21, 2025 /PRNewswire/ -- Mass tort and personal injury law firm, Rubenstein Law, proudly announces that Partner Miriam Fresco Agrait has been appointed by the Honorable M. Casey Rodgers of the United States District Court for Norther District of Florida to the Data Administration Steering Subcommittee in the ongoing Depo-Provera litigation. This prestigious appointment underscores Mrs. Agrait's legal acumen and commitment to justice in complex pharmaceutical litigation.

Mrs. Agrait brings extensive experience in mass torts and product liability cases, making her an invaluable addition to the subcommittee. In this role, she will assist in overseeing the management and organization of critical data, ensuring the integrity and accessibility of vital case information.

"We are incredibly proud of Miriam's appointment to this subcommittee," said Nicole Rubenstein Armstrong, CEO of Rubenstein Law. "Her dedication, experience, and expertise will undoubtedly contribute to the fair and efficient administration of this litigation."

The Depo-Provera litigation arises from claims that prolonged use of Depo-Provera significantly increases the risk of developing meningioma, a serious type of brain tumor. Plaintiffs claim that the manufacturer failed to adequately warn users about this potential health hazard.

Mrs. Agrait's appointment further solidifies Rubenstein Law's reputation as a leader in mass tort and pharmaceutical litigation. The firm remains committed to advocating for those affected by corporate negligence and ensuring justice prevails.

For media inquiries or further information, please contact:

Katie Amor
Chief Creative Officer
Rubenstein Law
786-230-2017
[emailprotected]
www.RubensteinLaw.com

SOURCE Rubenstein Law